Prostate cancer drug that can halve death risk to be offered to thousands in England

At least 6,000 men a year with hormone-sensitive cancer to get access to darolutamide, which blocks growth with fewer side-effects

 

https://www.theguardian.com/society/2025/oct/24/prostate-cancer-drug-darolutamide-to-be-offered-england-nhs